![](/img/cover-not-exists.png)
One Agent-Once a Day: 2 Year Outcomes of a Prospective Randomized Trial of Once Daily (Extended Release) Tacrolimus Maintenance Monotherapy vs Twice Daily (Standard Release) Tacrolimus After Alemtuzumab Induction & Early Steroid Cessation (TAESR Trial). Rejection and Variation in Tacrolimus Levels.
McLean, A., Brookes, P., Charif, R., Cook, T., Galliford, J., Goodall, D., Lee, J., Roufosse, C., Willicombe, M., Taube, D.Volume:
98
Journal:
Transplantation
DOI:
10.1097/00007890-201407151-01798
Date:
July, 2014
File:
PDF, 224 KB
2014